Mary Condie
About Mary Condie
Mary Condie is a Key Account Manager in Immuno-Oncology at Bristol-Myers Squibb, with over 14 years of experience in various roles within the company.
Current Role at Bristol-Myers Squibb
Mary Condie is currently working as a Key Account Manager- Immuno-Oncology at Bristol-Myers Squibb in the Ottawa, Canada area. In this role, she is responsible for managing key accounts within the immuno-oncology sector, leveraging her extensive experience in the industry.
Previous Roles at Bristol-Myers Squibb
Mary Condie has held multiple positions at Bristol-Myers Squibb over her 14-year tenure. She served as a Specialist Representative Oncology from 2014 to 2015 and as a Neuroscience Specialty Representative from 2009 to 2014, both in the Ottawa, Canada area. These roles were crucial in her career development and transition from neuroscience to oncology.
Educational Background
Mary Condie achieved a Bachelor’s Degree in Nursing Science from the University of Ottawa, where she studied between 1985 and 1987. Prior to that, she completed a three-year program at Vanier College, achieving her qualification as a Registered Nursing/Registered Nurse from 1982 to 1985. Her educational background laid the foundation for her extensive career in the healthcare and pharmaceutical industries.
Experience in Oncology and Immuno-Oncology
With over a decade of experience in the field of oncology, Mary Condie has specialized in immuno-oncology for more than 8 years. This extensive experience has equipped her with the necessary skills and knowledge to effectively manage key accounts and contribute significantly to the development and implementation of strategic initiatives within Bristol-Myers Squibb.
Industry Expertise
Mary Condie has comprehensive experience managing key accounts in the pharmaceutical industry. Her career at Bristol-Myers Squibb has seen her transition from neuroscience to oncology, adapting and excelling in various roles over the years. This adaptability and depth of experience underscore her expertise in the pharmaceutical field, particularly in oncology and immuno-oncology.